FDA mulls behind-the-counter drug sales

Once, the gap between prescription drugs and over-the-counter sales was a wide No Man's Land where few products roamed. Now, the FDA may settle more medications in this country, known as behind-the-counter (BTC) sales, in part to improve access for the uninsured.

The agency is seeking public comment on the potential move, which would allow patients to buy certain remedies after consultation with a pharmacist. Though the FDA won't cite specific meds that might be included, experts cite birth control pills [1] and cholesterol-lowering remedies [2] as possibilities.

- see the AP article [3]

Related Articles:
House overhauls, passes PDUFA. Report [4]
FDA clears Plan B, ending FDA confirmation fight. Report [1]